<p>(<b>A</b>) HCV infection of hepatocytes and antigen uptake and presentation by liver-resident and circulating antigen presenting cells (APCS) prime HCV-specific CTLs and helper CD4 T cells including Th1 and Th17 cells. Function and survival of HCV-specific CTLs are sustained by increased production of IL-21 by Th17 cells during the late acute phase of spontaneously resolving HCV infection. (<b>B</b>) In patients with chronic evolution, multiple inhibitory mechanisms cooperate to induce failure of the immune response and facilitate viral persistence. (1) HCV-specific Th17 cells produce less IL-21 thus compromising CTL survival and function. (2) HCV-specific CTLs become exhausted and up-regulate exhaustion molecules like Tim-3, PD-1 and CT...
Abstract: The hepatitis C virus (HCV) is a global health problem affecting more than 170 million peo...
Hepatitis C virus (HCV) represents a challenging global health threat to similar to 200 million infe...
Reports have shown that a negative T cell costimulatory pathway mediated by PD-1 (programmed death-1...
Loss of CD4 T cell help correlates with virus persistence during acute hepatitis C virus (HCV) infec...
<div><p>Loss of CD4 T cell help correlates with virus persistence during acute hepatitis C virus (HC...
<p>(<b>A</b>) IL-21 enhances expansion of HCV-specific CD8 T cells in a Tim-3-dependent manner. PBMC...
<p>(<b>A</b>) Level of expression of Tim-3 defines differential exhaustion statuses of HCV-specific ...
Approximately 200 million people throughout the world are infected with hepatitis C virus (HCV). One...
<p>HCV infection of hepatocytes results in the release of progeny HCV virions and extracellular vesi...
<p>(<b>A</b>) Representative FACS plot demonstrating enhanced production of Th17 and Th1 cytokines b...
Interleukin-21 (IL-21)+CD4+ T cells are involved in the immune response against hepatitis B virus (H...
textabstractThe hepatitis C virus (HCV) is very successful in establishing persistent infections by ...
Hepatitis C virus (HCV) is a blood-borne pathogen that infects hepatocytes and causes widespread d...
The hepatitis C virus (HCV) is a global health problem affecting more than 170 million people. A ch...
<p>During HCV infection, the virus is first recognized by TLRs and RIG-1, which in turn activates My...
Abstract: The hepatitis C virus (HCV) is a global health problem affecting more than 170 million peo...
Hepatitis C virus (HCV) represents a challenging global health threat to similar to 200 million infe...
Reports have shown that a negative T cell costimulatory pathway mediated by PD-1 (programmed death-1...
Loss of CD4 T cell help correlates with virus persistence during acute hepatitis C virus (HCV) infec...
<div><p>Loss of CD4 T cell help correlates with virus persistence during acute hepatitis C virus (HC...
<p>(<b>A</b>) IL-21 enhances expansion of HCV-specific CD8 T cells in a Tim-3-dependent manner. PBMC...
<p>(<b>A</b>) Level of expression of Tim-3 defines differential exhaustion statuses of HCV-specific ...
Approximately 200 million people throughout the world are infected with hepatitis C virus (HCV). One...
<p>HCV infection of hepatocytes results in the release of progeny HCV virions and extracellular vesi...
<p>(<b>A</b>) Representative FACS plot demonstrating enhanced production of Th17 and Th1 cytokines b...
Interleukin-21 (IL-21)+CD4+ T cells are involved in the immune response against hepatitis B virus (H...
textabstractThe hepatitis C virus (HCV) is very successful in establishing persistent infections by ...
Hepatitis C virus (HCV) is a blood-borne pathogen that infects hepatocytes and causes widespread d...
The hepatitis C virus (HCV) is a global health problem affecting more than 170 million people. A ch...
<p>During HCV infection, the virus is first recognized by TLRs and RIG-1, which in turn activates My...
Abstract: The hepatitis C virus (HCV) is a global health problem affecting more than 170 million peo...
Hepatitis C virus (HCV) represents a challenging global health threat to similar to 200 million infe...
Reports have shown that a negative T cell costimulatory pathway mediated by PD-1 (programmed death-1...